Murrough, Iosifescu, Chang et al. Antidepressant Efficacy in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial Am J Psychiatry. 2013 Oct 1, 170(10): 1134-1142 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992936/
Murrough, Perez, Pillemer, et al.. Rapid and Longer0Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression Biol Psychiatry 2013 Aug 15; 74(4): 250-256 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725185/
Murrough, Burdick, Levitch et al. Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial Neuropsychopharmacology 2015 Apr; 40(5): 1084-1090 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367458/
Schwartz, Murrough, Iosifescu Ketamine for treatment-resistant depression: recent developments and clinical applications Evid Based Ment Health 2016 May; 19(2):35-8 http://ebmh.bmj.com/content/ebmental/19/2/35.full.pdf
Singh, Fedgchin, Daly et al. A Double-Blind, Randomized, Pacebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression American Journal of Psychiatry 2016 August; 173(8): 816-826 http://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2016.16010037
Taylor, Landeros-Weisenberger, Coughlin et al. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial Neuropsychopharmacology 2017 August; https://www.ncbi.nlm.nih.gov/pubmed/28849779